EUVIMEDEUVIMED entdecken
Crossref

The protective role of transcription factor Nrf2 in murine macrophage activation syndrome

Paul M Gallo iD, Em Elliott, Grace C Ford, Chhanda Biswas, Jadyn M Wheaton, Jihwan Kim, Connie L Jiang, Niansheng Chu, Portia A Kreiger, Michele P Lambert, Edward M Behrens

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiae225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Paul M Gallo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, United States. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Macrophage Activation Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Nancy Taylor Foundation for Chronic Diseases, Pediatric Hematology Research Training Program National Heart, Lung, and Blood Institute T32, Penn Summer Undergraduate Internship Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Macrophage activation syndrome (MAS) is characterized by multilineage cytopenias, hypercytokinemia, and tissue hemophagocytosis. Transcription factor Nrf2 is a master regulator of redox homeostasis. In this work, we aim to investigate the role of Nrf2 in murine hyperinflammation and the mechanisms by which Nrf2 activation by red blood cell products regulates proinflammatory cytokine production.

Methods

We induced murine MAS in wild-type and Nrf2 knockout (Nrf2−/−) mice by repeat administration of TLR9-agonist CpG. Clinical and biochemical markers of disease were measured including complete blood counts, liver and spleen pathology, serum free heme, ferritin, and cytokine profiles. In vitro bone marrow–derived macrophages and dendritic cells were used to investigate regulation of CpG-induced cytokine expression by oxidized red blood cells and hemin.

Results

Patients with hyperinflammatory disease had higher levels of Nrf2 gene expression. Mice with CpG-induced hyperinflammation had elevated systemic lipid peroxidation, which was exacerbated in Nrf2−/− mice. Compared with wild-type control mice, Nrf2−/− mice developed significantly worse organomegaly, organ pathology, and reticulocytosis. Nrf2−/− mice had exacerbated hypercytokinemia in cytokines central MAS physiology: interleukin (IL)-12, interferon γ, and IL-10. In vitro, we found that oxidized red blood cell lysates and hemin were able to suppress IL-12 transcription and protein production from bone marrow–derived dendritic cells in an Nrf2-dependent manner.

Conclusion

Together, our findings show that transcription factor Nrf2 is highly expressed in patients with hyperinflammatory disease and demonstrate a protective role for Nrf2 in a murine model of MAS in part due to Nrf2-mediated suppression of proinflammatory cytokine production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Macrophage Activation SyndromeAnimalsMiceMice, KnockoutCytokinesHumansMacrophagesMice, Inbred C57BLDendritic CellsMaleDisease Models, Animal

Stichwörter der Autor:innen

hemophagocytosisinflammationmacrophage activation syndrome

Substanzen

NF-E2-Related Factor 2Nfe2l2 protein, mouseCytokines

Autor:innen und Institutionen

  • Division of Hematology, Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, United States.
  • Division of Rheumatology, Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, United States.
  • Division of Pathology, Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Philadelphia, PA 19104, United States.

ORCID-Profile: Paul M Gallo

Förderung

  • Nancy Taylor Foundation for Chronic Diseases
  • Pediatric Hematology Research Training Program National Heart, Lung, and Blood Institute T32
  • Penn Summer Undergraduate Internship Program

Zitieren

APA

Gallo, P. M., Elliott, E., Ford, G. C., Biswas, C., Wheaton, J. M., Kim, J., Jiang, C. L., Chu, N., Kreiger, P. A., Lambert, M. P., & Behrens, E. M. (2025). The protective role of transcription factor Nrf2 in murine macrophage activation syndrome. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae225

Vancouver

Gallo PM, Elliott E, Ford GC, Biswas C, Wheaton JM, Kim J, et al. The protective role of transcription factor Nrf2 in murine macrophage activation syndrome. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae225

BibTeX
@article{Gallo2025,
  author = {Gallo, Paul M and Elliott, Em and Ford, Grace C and Biswas, Chhanda and Wheaton, Jadyn M and Kim, Jihwan and Jiang, Connie L and Chu, Niansheng and Kreiger, Portia A and Lambert, Michele P and Behrens, Edward M},
  title = {The protective role of transcription factor Nrf2 in murine macrophage activation syndrome},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiae225}
}
Kostenlos starten →